• Author: Kristina L. Bajema
Clear all

Durability of respiratory syncytial virus vaccine effectiveness among US Veterans

Abstract: Importance: A single respiratory syncytial virus (RSV) vaccine dose is recommended for older adults and persons at increased risk for severe RSV. Clinical information on …

Low uptake and disparities in respiratory syncytial virus vaccination among US Veterans open access

Abstract: This cohort study of US Veterans identifies low respiratory syncytial virus vaccine uptake among eligible persons (9.8% in the 2023–2024 season, 3.0% after 5 months of …

Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients, March 2022-April 2023

Abstract: Objective: The epidemiology of COVID-19 has substantially changed since its emergence given the availability of effective vaccines, circulation of different viral …

Identifying Veterans who benefit from nirmatrelvir-ritonavir: A target trial emulation

Abstract: Background: Nirmatrelvir-ritonavir is recommended for persons at risk for severe coronavirus disease 2019 (COVID-19) but remains underutilized. Information on which …

Changes in outpatient health care use after COVID-19 infection among Veterans

Abstract: Importance The association of COVID-19 infection with outpatient care utilization is unclear. Many studies reported population surveillance studies rather than comparing …

Effectiveness of nirmatrelvir-ritonavir against the development of post-covid-19 conditions among U.S. veterans: a target trial emulation

Abstract: Background: COVID-19 has been linked to the development of many post-COVID-19 conditions (PCCs) after acute infection. Limited information is available on the …